Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
dihydroartemisinin (1 trial)
piperaquine (1 trial)
Malaria (Phase 4)
Trials (1 total)
Trial APIs (2 total)